These pathways align with the existing literature, where frequent activation of the PI3K/AKT/mTOR pathway [40], or recurrent mutations and aberrant expression of MAPK [41] or Rap1 [42] genes have been reported in MM patients. This evidence concerns the gene MTOR and Miyoshi myopathy.